Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

GP sees patient with vCJD improve

Dr Mark McClean has reported cautious signs of improvement in one of his patients with variant Creutzfeldt-Jakob disease (vCJD) who is being treated with a revolutionary new drug.

Dr McClean, a GP in Belfast, said his patient, 18-year-old Jonathan Simms, was 'bound to die' a year ago but since starting treatment with the experimental drug Pentosan in January, the deterioration has stopped.

Jonathan had to fight a High Court battle to have the treatment as the drug at that stage had only been tested on dogs and mice.

Dr McClean said: 'He has demonstrated greater response to auditory, visual and tactile stimuli.'

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say